MICRO-X LIMITED — Investor Presentation 2021

Oct 4, 2021

==> picture [159 x 46] intentionally omitted <==

Micro-X Limited, ABN 21 153 273 735

MORGANS ANNUAL INVESTOR CONFERENCE

Micro-X to present to Morgans Institutional Conference on 6 October 2021

Adelaide, Australia, 5[th] October 2021: Australian hi-tech company Micro-X Ltd (ASX:MX1) ( Micro-X or the Company ), a leader in cold cathode x-ray technology for health and security markets globally, is pleased to announce that Micro-X will be presenting at the Morgans Investor Conference on 6 October 2021 (AEDT).

The Morgans Investor Conference is held annually and is one of Australia’s longest running institutional conferences. This year’s conference includes three days of small and large cap company presentations from 5[th] October 2021 to 7[th] October 2021. Micro-X CEO and Managing Director, Peter Rowland will be presenting a session on the Company.

Morgans Financial Limited is Australia’s largest full-service stockbroking and wealth management network, servicing over 240,000 client accounts with over 950 employees operating from offices in all states and territories.

This ASX Announcement is authorised by Kingsley Hall, Company Secretary of Micro-X.

– ENDS –

About Micro-X

Micro-X Limited (the Company ) is an ASX listed hi-tech company developing and commercialising a range of innovative products for global health and security markets, based on proprietary cold cathode, carbon nanotube (CNT) emitter technology. The electronic control of emitters with this technology enables x-ray products with significant reduction in size, weight and power requirements, enabling greater mobility and ease of use in existing x-ray markets and a range of new and unique security and defence applications. Micro-X has a fully vertically integrated design and production facility in Adelaide, Australia. A growing technical and commercial team based in Seattle is rapidly expanding Micro-X’s US business.

Micro-X’s product portfolio is built in four, high margin, product lines in health and security. The first commercial mobile digital radiology products are currently sold for diagnostic imaging in global healthcare, military and veterinary applications. An X-ray Camera for security imaging of Improvised Explosive Devices is in advanced development. The US Department of Homeland Security has selected Micro-X to design a next-generation Airport Checkpoint Portal with self-service x-ray. A miniature brain CT imager for pre-hospital stroke diagnosis in ambulances, is being developed with funding from the Australian Government’s Medical Research Future Fund.

For more information visit: www.micro-x.com

CONTACTS

	Micro-X Limited			Investor Enquiries
	Peter Rowland			David Allen / John Granger
	Managing DirectorTel: +61 8 7099 3966E:admin@micro-x.com			Hawkesbury PartnersTel: +61 2 9103 9494E:dallen@hawkesburypartners.com jgranger@hawkesburypartners.com

Micro-X Limited, ABN 21 153 273 735, 1284 South Road, Tonsley, South Australia, 5042, AUSTRALIA

www.micro-x.com